ArticleStem cell research & therapy2025

iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis.

Takefumi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.